Robert Doherty
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Brain DevelopmentGoogle:
"Robert Doherty"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kadiyala P, Li D, Nunez FM, et al. (2019) High Density Lipoprotein-Mimicking Nanodiscs for Chemo-Immunotherapy against Glioblastoma Multiforme. Acs Nano |
| Shah D, Kadiyala P, Kamran N, et al. (2017) IMMU-26. TLR7 ACTIVATION IS ESSENTIAL FOR NK CELLS TO ELIMINATE GLIOMA TUMORS Neuro-Oncology. 19: vi118-vi118 |
| Koschmann C, Zamler D, MacKay A, et al. (2016) Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma. Oncotarget |
| Wilson TJ, Zamler DB, Doherty R, et al. (2016) Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior. Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells. Oncotarget |
| Calinescu AA, Yadav VN, Carballo E, et al. (2016) Survival and proliferation of neural progenitor derived glioblastomas under hypoxic stress is controlled by a CXCL12/CXCR4 autocrine positive feedback mechanism. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Koschmann C, Calinescu AA, Nunez FJ, et al. (2016) ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma. Science Translational Medicine. 8: 328ra28 |
| Calinescu A, Carballo E, Tran D, et al. (2015) TMOD-02BLOCKING CXCR4 INCREASES SURVIVAL IN A MOUSE MODEL OF NEURAL STEM CELLS-DERIVED GLIOBLASTOMA BY BLOCKING AN AUTOCRINE POSITIVE FEEDBACK LOOP REGULATING APOPTOSIS AND CELL CYCLE PROGRESSION VIA Rb1 AND cdk4/cdk6/CyclinD1 Neuro-Oncology. 17: v226.2-v226 |
| VanderVeen N, Paran C, Appelhans A, et al. (2014) Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors. Molecular Therapy. Methods & Clinical Development. 1 |
| Baker GJ, Chockley P, Yadav VN, et al. (2014) Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity. Cancer Research. 74: 5079-90 |
| Assi H, Espinosa J, Suprise S, et al. (2014) Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. Plos One. 9: e96318 |